<p>Tiago Marques, Chief Executive Officer and Director of Pasithea Therapeutics Corporation, reported the acquisition of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pasithea Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-116301), on December 01, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

KTTA

<p>Tiago Marques, CEO and Director of Pasithea Therapeutics, reported acquiring common shares of the company. The full filing is available via EDGAR, the U.S. SEC's system. This AI-generated news brief by Public Technologies is for informational purposes only and not financial advice. The original content was published by Pasithea Therapeutics on December 01, 2025.</p>

Pasithea Therapeutics CEO Tiago Marques Reports Acquisition of Common Shares